United Imaging Enters the Booming $10B Surgical Robot Market with Approval of Its Thoracoabdominal Endoscopic Robotic System

January 5,The information on the delivery of medical device approval documents released by the National Medical Products Administration shows,Wuhan United Imaging Healthcare Surgical Technology Co., Ltd.'s Thoracoabdominal Endoscopic Surgical System Approved, Officially Entering the Competition in the Field of Endoscopic Surgical Robotics.

For a long time, the global market for endoscopic surgical robots has been dominated by giants such as the American Intuitive Surgical's Da Vinci System and Medtronic's HUGO.

From the bidding data of China's endoscopic surgical robot market from January to November 2025, Intuitive Surgical (Da Vinci Robot), with its deep clinical accumulation and brand advantages, captured 67.90% of the market share in this细分领域 with sales of 55 units. Its average unit price reached a staggering 18.566 million yuan, establishing an extremely high value barrier. Chinese-produced brands such as Edge Medical (16 units) and MicroPort (14 units) have achieved bulk sales, with their average unit prices (ranging from 10 to 19 million yuan) gradually approaching or even surpassing imported brands in certain models.

As early as 2019, Wuhan United Imaging Healthcare Surgical Technology Co., Ltd. was established. With "image-guided" technology at its core, the company has built a surgical robot product matrix covering "all departments," including neurosurgery, orthopedics, and interventional procedures. Multiple products have been approved and put into clinical use. Following the approval of its first endoscopic surgical robot, the company has achieved commercial layout in the first and second largest segments of the surgical robot market.

It is reported that, under the support of the "Sharp Blade" project, Wuhan United Imaging Healthcare Surgical Technology Co., Ltd. collaborated with more than 10 organizations, including hospitals, universities, and supply chain enterprises, to carry out joint research efforts, shortening the development cycle by over a year.

Traditional surgical robots generally have two major pain points: First, the lack of tactile feedback makes it difficult for doctors to perceive critical information such as tissue hardness and vascular elasticity, which can easily lead to risks due to inaccurate force control. Second, reliance on surface imaging prevents the observation of internal structures through tissues, limiting precision.

Public information shows that the core breakthrough of Wuhan United Imaging Healthcare Surgical Technology Co., Ltd.'s endoscopic surgical robot is embodied in the technological innovation of "3D perception + intelligent collaboration."

• In terms of imaging, it pioneers multi-modal image fusion technology, intelligently overlaying preoperative 3D CT/MRI data with real-time intraoperative images, breaking through the limitations of traditional endoscopic "surface imaging" to help doctors "see through" internal tissue vasculature and lesion distribution.

• At the operational level, develop multi-degree-of-freedom surgical instruments with interactive force perception, giving robots "dexterous hands" capable of precisely controlling subtle forces.

• In terms of efficiency, the intelligent positioning technology enables rapid and precise automatic adjustment of the surgical arm during the operation, significantly reducing the lengthy preoperative preparation and intraoperative adjustment time.

At the same time, the team has completed the full-chain independent research and development of core components such as high-definition 3D endoscopes and high-precision surgical arms, achieving 100% localization in China.

By 2026, the surgical robot sector in China will witness a historic turning point under policy guidance; a new landscape of diverse growth is eagerly anticipated.

ExpansionReading:Dual Implementation of Medical Insurance and Charging, the Billion-Dollar Surgical Robot Track Welcomes a New Era by 2026